Skip to main content

Table 1 Baseline characteristics of participants in the Malmö Preventive Project (MPP) stratified by sex

From: The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden

  All Men Women
Sex, men n (%) 33,335 22,433 (67.3) 10,902 (32.7)
Age* (years) 45.7 (7.4) 43.7 (6.6) 49.7 (7.4)
BMI (kg/m2) 24.6 (3.6) 24.7 (3.3) 24.4 (4.2)
Serum urate (micromol/L) 300.8 (70.1) 323.2 (64.2) 254.4 (57.8)
Seum urate > 405, n (%) 2455 (7.1%) 2191 (9.8%) 164 (1.5%)
SBP in individuals with non-treated hypertension at baseline (mmHg)** 149 (21) 150 (20) 148 (21)
Fasting glucose (millimol/L) in non-DM individuals at baseline 4.9 (0.5) 4.9 (0.5) 4.8(0.5)
eGFR (ml/min/1.73m2) 77.9 (10.8) 79.1 (10.5) 75.6 (10.9)
Cholesterol (milimol/L) 5.7 (1.1) 5.6 (1.1) 5.8 (1.1)
Triglycerides (milimol/L) 1.4 (0.9) 1.5 (1.1) 1.1(0.6)
Hypertension at baseline n (%)§ 6070 (17.2) 3672 (16.4) 2398 (22)
Diabetes mellitus at baseline, n (%)§§ 828 (2.5) 575 (2.6) 253 (2.3)
Family history of any sibling having hypertension, n (%) 2519 (7.6) 1102 (4.9) 1417 (13)
History of kidney stone attack, n (%) 2729 (8.2) 2003 (8.9) 726 (6.7)
History of several kidney stone attacks, n (%) 1359 (4.1) 1046 (4.7) 313 (2.9)
Mm-MAST ≥ 2, n (%)# 21.7 30.8 2.8
ESR (mm/hour) 7.1 (6.9) 5.7 (6.0) 9.9 (7.7)
Current smoker, n (%) 14,846 (44.5) 11,038 (49.2) 3808 (37.1)
  1. *Values for continuous variables denote mean (SD)
  2. **Number of patients are 2780 male and 1416 female)
  3. #Number of subjects are 6920 (male) and 310 (female)
  4. §Hypertension was defined as systolic BTP ≥ 160 mmHg or using antihypertensive treatment on the regular basis
  5. §§Diabetes mellitus at baseline was defined as f-glucose ≥ 6.7 or history of DM.
  6. SBP systolic blood pressure, Mm-MAST Malmö-modified brief Michigan Alcohol Screening Test, ESR erythrocyte sedimentation rate